Investment Management Of Virginia Lowers stake in Quidel Corporation (QDEL)

Quidel Corporation (QDEL) : Investment Management Of Virginia reduced its stake in Quidel Corporation by 0.62% during the most recent quarter end. The investment management company now holds a total of 407,667 shares of Quidel Corporation which is valued at $9,111,357 after selling 2,560 shares in Quidel Corporation , the firm said in a disclosure report filed with the SEC on Aug 12, 2016.Quidel Corporation makes up approximately 2.21% of Investment Management Of Virginia’s portfolio.

Other Hedge Funds, Including , Menta Capital reduced its stake in QDEL by selling 3,089 shares or 7.76% in the most recent quarter. The Hedge Fund company now holds 36,715 shares of QDEL which is valued at $820,580. Quidel Corporation makes up approx 0.11% of Menta Capital’s portfolio.Baird Financial Group boosted its stake in QDEL in the latest quarter, The investment management firm added 76,639 additional shares and now holds a total of 300,847 shares of Quidel Corporation which is valued at $6,723,930. Quidel Corporation makes up approx 0.06% of Baird Financial Group’s portfolio.Teachers Advisors Inc boosted its stake in QDEL in the latest quarter, The investment management firm added 351 additional shares and now holds a total of 47,034 shares of Quidel Corporation which is valued at $1,051,210.

Quidel Corporation opened for trading at $21.61 and hit $21.9 on the upside on Monday, eventually ending the session at $21.73, with a gain of 0.65% or 0.14 points. The heightened volatility saw the trading volume jump to 1,28,139 shares. Company has a market cap of $704 M.

On the company’s financial health, Quidel Corporation reported $-0.11 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $-0.13. The company had revenue of $39.10 million for the quarter, compared to analysts expectations of $38.02 million. The company’s revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.14 EPS.

Many Wall Street Analysts have commented on Quidel Corporation. Quidel Corporation was Upgraded by Raymond James to ” Outperform” on Jun 13, 2016.

Quidel Corporation is engaged in the development manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions primarily include applications in infectious diseases women’s health and gastrointestinal diseases. The Company sells its products directly to end users and distributors in each case for professional use in physician offices hospitals clinical laboratories reference laboratories universities retail clinics and wellness screening centers. It markets its products in the United States through a network of national and regional distributors and a direct sales force. Internationally it sells and markets primarily through distributor arrangements. Its diagnostic solutions are used in the detection and diagnosis of many critical diseases and other medical conditions including infectious diseases women’s health autoimmune diseases bone health thyroid diseases and fecal occult blood.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Quidel Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Quidel Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.